Literature DB >> 8818890

Detection and characterization of antigens in urine of patients with acute, congenital, and chronic Chagas' disease.

R S Corral1, J Altcheh, S R Alexandre, S Grinstein, H Freilij, A M Katzin.   

Abstract

Monoclonal antibodies raised against purified Trypanosoma cruzi urinary antigens were used in an enzyme-linked immunosorbent assay (ELISA) capture test for parasite antigens present in urine specimens of Argentinean and Brazilian patients with Chagas' disease. At diagnosis, antigenuria was demonstrated by ELISA in all acutely and congenitally infected infants studied. Moreover, T. cruzi urinary antigens were detected in samples from three of five patients with acute infections and four of five patients with congenital infections following chemotherapy. At least one ELISA-positive urine specimen from each individual was recorded in a longitudinal survey of 12 chronic chagasic patients. The same parasitic antigens (90 to 80 kDa, pI 5.7 to 6.0; 70 to 65 kDa, pI 4.9 to 4.5; 50 to 45 kDa, pI 5.3 to 5.1; and 40 to 35 kDa, pI 4.8 to 4.5) were identified by immunoprecipitation and two-dimensional polyacrylamide gel electrophoresis analysis of urine samples from patients with different forms of chagasic infection. The 90- to 80-kDa urinary protein resembles a trypomastigote-shed antigen. Determination of antigenuria proved valuable for early diagnosis of Chagas' disease and also for diagnosis of chronic cases with conflicting serology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818890      PMCID: PMC229162          DOI: 10.1128/jcm.34.8.1957-1962.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere.

Authors:  Z Brener
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Detection of circulating antigens of Trypanosoma cruzi by enzyme immunoassay.

Authors:  F G Araujo
Journal:  Ann Trop Med Parasitol       Date:  1982-02

Review 5.  Biology of Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

6.  An iron-binding Trypanosoma cruzi urinary antigen.

Authors:  R S Corral; G M Bertot; P B Petray; J M Altcheh; M Singh; A Orn; M F Rapoport; S Grinstein
Journal:  Parasite       Date:  1995-12       Impact factor: 3.000

7.  Adhesion and interiorization of Trypanosoma cruzi in mammalian cells.

Authors:  N W Andrews; W Colli
Journal:  J Protozool       Date:  1982-05

8.  Congenital Chagas' disease: diagnostic and clinical aspects.

Authors:  H Freilij; J Altcheh
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

9.  High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.

Authors:  M E Solana; A M Katzin; E S Umezawa; C S Miatello
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

10.  Demonstration of Trypanosoma cruzi antigen in serum from patients with Chagas' disease.

Authors:  F G Araujo; E Chiari; J C Dias
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

View more
  8 in total

1.  Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up.

Authors:  C Riera; R Fisa; P Lopez; E Ribera; J Carrió; V Falcó; I Molina; M Gállego; M Portús
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

2.  Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

Authors:  Verónica Yauri; Yagahira E Castro-Sesquen; Manuela Verastegui; Noelia Angulo; Fernando Recuenco; Ines Cabello; Edith Malaga; Caryn Bern; Cesar M Gavidia; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

Review 3.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

4.  Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.

Authors:  Rana Nagarkatti; Fernanda Fortes de Araujo; Charu Gupta; Alain Debrabant
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

5.  Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Gerson Galdos-Cardenas; Lisbeth Ferrufino; Gerardo Sánchez; Edward Valencia Ayala; Lance Liotta; Caryn Bern; Alessandra Luchini
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

6.  Polyclonal antibodies for the detection of Trypanosoma cruzi circulating antigens.

Authors:  Edith S Málaga-Machaca; Alessandra Romero-Ramirez; Robert H Gilman; Sofía Astupiña-Figueroa; Noelia Angulo; Alejandro Florentini; Cinthya J Lovon-Luque; Remo A Gonza; Ada Del Carpio-Sanz; Inés Cabello; Rosina Camargo; Fernando Recuenco; Liliam A Barrueta-Soria; Manuela R Verastegui; Maritza Calderon; Holger Mayta
Journal:  PLoS Negl Trop Dis       Date:  2017-11-09

Review 7.  Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease.

Authors:  Luíza Dantas-Pereira; Rubem Menna-Barreto; Joseli Lannes-Vieira
Journal:  Front Cell Dev Biol       Date:  2021-12-20

8.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.